aspirin has been researched along with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, FC; Huang, LJ; Huang, TM; Kuo, SC; Lee, FY; Lien, JC; Teng, CM; Tsai, SC; Wu, CC | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Kong, Y; Li, S; Liu, S; Wang, E; Xie, R; Yuan, D; Zhang, W; Zhu, X | 1 |
1 review(s) available for aspirin and 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
| Article | Year |
|---|---|
Protease activated receptor 4 (PAR4) antagonists: Research progress on small molecules in the field of antiplatelet agents.
Topics: Animals; Blood Platelets; Drug Discovery; Humans; Indazoles; Indoles; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Small Molecule Libraries; Thiadiazoles | 2021 |
2 other study(ies) available for aspirin and 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
| Article | Year |
|---|---|
Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Cyclic Nucleotide Phosphodiesterases, Type 5; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; Indazoles; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Cytoplasmic and Nuclear; Receptors, Thrombin; Soluble Guanylyl Cyclase; Structure-Activity Relationship | 2001 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |